PPARD and Huntington disease: However, a relevant recent study found PPARβ/δ to be repressed by the mutant form of huntingtin (HTT) in Huntington’s disease (HD), while its activation reverted transcriptional alterations associated with neurodegeneration, motor impairments and mitochondrial abnormalities in experimental models of HD [39,40].